Chemocentryx (CCXI) Posts Q1 Loss of 28c/Share

Chemocentryx (NASDAQ: CCXI) reported Q1 EPS of ($0.28), $0.07 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.02 million versus the consensus estimate of $4.75 million.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• RenaissanceRe Holdings' (RNR) Lack of Growth Creates Challenging Earnings Outlook: Analyst
• Popular (BPOP) Tops Q2 EPS by 64c